Publications by authors named "Marianna Desideri"

26Publications

Inhibition of lysine acetyltransferases impairs tumor angiogenesis acting on both endothelial and tumor cells.

J Exp Clin Cancer Res 2020 Jun 5;39(1):103. Epub 2020 Jun 5.

Preclinical Models and New Therapeutic Agents Unit, Department of Research and Advanced Technologies, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

View Article and Find Full Text PDF
June 2020

BCL-X overexpression promotes tumor progression-associated properties.

Cell Death Dis 2017 12 13;8(12):3216. Epub 2017 Dec 13.

Preclinical Models and New Therapeutic Agents Unit, Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.

View Article and Find Full Text PDF
December 2017

NAADP-Dependent Ca(2+) Signaling Controls Melanoma Progression, Metastatic Dissemination and Neoangiogenesis.

Sci Rep 2016 Jan 6;6:18925. Epub 2016 Jan 6.

Department of Anatomy, Histology, Forensic Medicine and Orthopaedics, Unit of Histology and Medical Embryology,SAPIENZA University of Rome, 16 Via A. Scarpa, 00161 Rome, Italy.

View Article and Find Full Text PDF
January 2016

TLR3 engagement induces IRF-3-dependent apoptosis in androgen-sensitive prostate cancer cells and inhibits tumour growth in vivo.

J Cell Mol Med 2015 Feb 2;19(2):327-39. Epub 2014 Dec 2.

Istituto Pasteur-Fondazione Cenci Bolognetti, Department of Anatomy, Histology, Forensic Medicine and Orthopedics, Section of Histology and Medical Embryology, Sapienza University of Rome, Rome, Italy.

View Article and Find Full Text PDF
February 2015

VEGF-induced neoangiogenesis is mediated by NAADP and two-pore channel-2-dependent Ca2+ signaling.

Proc Natl Acad Sci U S A 2014 Nov 20;111(44):E4706-15. Epub 2014 Oct 20.

Department of Anatomy, Histology, Forensic Medicine and Orthopaedics, Unit of Histology and Medical Embryology, Sapienza University of Rome, 00161 Rome, Italy;

View Article and Find Full Text PDF
November 2014

Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression.

Eur J Cancer 2009 Sep 13;45(14):2618-27. Epub 2009 Aug 13.

Experimental Chemotherapy Laboratory, Regina Elena Cancer Institute, Via delle Messi d'Oro 156, Rome 00158, Italy.

View Article and Find Full Text PDF
September 2009

Antiangiogenic potential of the Mammalian target of rapamycin inhibitor temsirolimus.

Cancer Res 2006 Jun;66(11):5549-54

Laboratory of Experimental Chemotherapy and Division of Medical Oncology A, Regina Elena National Cancer Institute, Rome, Italy.

View Article and Find Full Text PDF
June 2006